<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5685">
  <stage>Registered</stage>
  <submitdate>28/04/2014</submitdate>
  <approvaldate>28/04/2014</approvaldate>
  <nctid>NCT02126631</nctid>
  <trial_identification>
    <studytitle>Sternal ECG Patch Comparison Trial</studytitle>
    <scientifictitle>Comparison of a Sternal ECG Patch With a Standard Recording System for Holter Monitoring</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>6147</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Syncope</healthcondition>
    <healthcondition>Presyncope</healthcondition>
    <healthcondition>Palpitations</healthcondition>
    <healthcondition>Atrial Fibrillation</healthcondition>
    <healthcondition>Supraventricular Tachycardia</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions />
    <comparator />
    <control />
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>ECG signal quality - ECG signal quality = scoring the ability of each system to record electrical activity from the atrium (P-waves). The Physician Event Committee will independently score the P-waves from all recordings, using the following scale: Excellent, Good, Fair, Poor, Non-existent. Diagnostic yield will also be assessed.</outcome>
      <timepoint>24 hours of patient use, plus shipping and analysis time ~ 2 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Device comfort - Secondary outcome measures will include Human Factors performance of the 2 systems, which will be scored and compared in the following areas and duration of patch adherence: skin irritation, comfort, contact and stability.</outcome>
      <timepoint>24 hours</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Syncope of uncertain etiology or

          -  Pre-syncope of uncertain etiology or

          -  Palpitations of uncertain etiology or

          -  Management of known AF/SVT patients</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Any dermatitis or infected skin over the sternum (Carnation patch) or left upper
             anterior thorax (Zio patch).

          -  A sternal or thoracic incision that extends under the patch within 3 months from the
             date of enrollment</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/07/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>50</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate>1/07/2014</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Bardy Diagnostics, Inc.</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study is intended to compare the new Carnation Ambulatory Monitoring (CAM) System, a
      patch monitoring system, with the Holter monitoring system. Holters represent the current
      standard for continuous recording of the ECG over extended periods.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02126631</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Jon Hunt, PhD</name>
      <address>Bardy Diagnostics, Inc. (sponsor)</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>